Aligned Study
Advertisement
The ALIGNED Study, based in Newtown, New South Wales, aims to investigate how pharmacogenomics can assist in identifying the most effective antidepressant medications for individuals suffering from depression. This research focuses on improving treatment outcomes and reducing adverse effects through a simple genetic test that evaluates a person's response to medication.
Eligible participants for the study must be aged between 18 and 80, reside in Australia, and currently have depression without taking antidepressants. Conducted via videoconference over approximately three months, the study collaborates with participants' general practitioners to assess the effectiveness of genotype-guided therapy compared to standard care.
Generated from the website
Also at this address
You might also like
Advertisement